Menu Close

Trending

Study exposes lack of diversity in US cancer trials
NHS England reveals travel plan to cut waiting lists
GSK hepatitis B hope bepirovirsen heads for phase 3 test
Ipsen beefs up in oncology, buying US biopharma Epizyme
BioMarin gene therapy for haemophilia on course for EU approval

Medscape

It’s time to rethink the physician-pharma relationship

Deep Dive/ Sales and Marketing/ Views & Analysis/ Views and analysis

It’s time to rethink the physician-pharma relationship

, , , , 0 Comment

The traditional sales channel for the pharmaceutical industry has centered on face-to-face interaction with its core target audience

X
It’s time to rethink the physician-pharma relationship
https://pharmaphorum.com/sales-marketing/its-time-to-rethink-the-physician-pharma-relationship/
COVID-19 – Delivering a pandemic of change to digital medical education

Deep Dive/ Patients/ Views & Analysis/ Views and analysis

COVID-19 – Delivering a pandemic of change to digital medical education

, , , , 0 Comment

As the world of medicine continues to deal with the impact of the COVID-19 pandemic, clinicians are moving

X
COVID-19 – Delivering a pandemic of change to digital medical education
https://pharmaphorum.com/views-analysis-patients/covid-19-delivering-a-pandemic-of-change-to-digital-medical-education/
The tools and techniques making virtual patient simulations more realistic than ever

Deep Dive/ Digital/ Views & Analysis/ Views and analysis

The tools and techniques making virtual patient simulations more realistic than ever

, , , 0 Comment

Patient simulations have been a key tool for educating physicians in some form for hundreds of years –

X
The tools and techniques making virtual patient simulations more realistic than ever
https://pharmaphorum.com/views-analysis-digital/the-tools-and-techniques-making-virtual-patient-simulations-more-realistic-than-ever/
Clinical decision-making insights for haematologists and oncologists

Digital/ Oncology/ Views & Analysis/ Views & Analysis/ Views and analysis

Clinical decision-making insights for haematologists and oncologists

, , , , , 0 Comment

Clinical trial readouts continue to emerge despite countries’ lockdown policies, providing several decision-making challenges for healthcare professionals such

X
Clinical decision-making insights for haematologists and oncologists
https://pharmaphorum.com/views-analysis-digital/clinical-decision-making-insights-for-haematologists-and-oncologists/
COVID-19-Insights_Impact-on-Clinicians

Digital/ Views & Analysis/ Views and analysis/ White Papers/ Whitepapers

COVID-19’s lasting impact on digital communication in healthcare

, , , 0 Comment

The ongoing digital transformation of the healthcare and pharmaceutical industries has been greatly accelerated during the coronavirus pandemic.

X
COVID-19’s lasting impact on digital communication in healthcare
https://pharmaphorum.com/whitepapers/covid-19s-lasting-impact-on-digital-communication-in-healthcare/
How to increase haematologists’ and oncologists’ confidence with new treatments

Deep Dive/ Oncology/ Views & Analysis/ Views and analysis

How to increase haematologists’ and oncologists’ confidence with new treatments

, , , , , , 0 Comment

A new whitepaper from Medscape highlights the difficulties haematologists and oncologists face in keeping up with rapid developments

X
How to increase haematologists’ and oncologists’ confidence with new treatments
https://pharmaphorum.com/views-analysis-oncology/how-to-increase-haematologists-and-oncologists-confidence-with-new-treatments/
1 2

Login

CONTINUE TO SITE >
X
Close in 10 seconds